Integrated Bulk and Single-Cell Transcriptomics Reveals the C3–C3AR1 Axis as a Candidate Mediator of Coagulome-Immune Crosstalk in Osteosarcoma

Jianhua Mu, Yitian Wang, Han Liu, Xuanhong He, Zhuangzhuang Li, Minxun Lu, Fan Tang, Yi Luo, Yong Zhou, Li Min, Chongqi Tu · 2026

Read Integrated Bulk and Single-Cell Transcriptomics Reveals the C3–C3AR1 Axis as a Candidate Mediator of Coagulome-Immune Crosstalk in Osteosarcoma by Jianhua Mu, Yitian Wang, Han Liu, Xuanhong He, Zhuangzhuang Li, Minxun Lu, Fan Tang, Yi Luo, Yong Zhou, Li Min, Chongqi Tu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13509456.txt.

Description

Jianhua Mu and ten co-authors examine how blood-clotting genes interact with the immune setting of osteosarcoma, a bone cancer seen mostly in teenagers, in 2026 work. The group combined large-scale gene readings with single-cell data and patient outcome records. They scored each tumor for clotting-related gene activity and traced which cell types carried that signal.

Tumors with high clotting scores tended to be more advanced, and the score helped predict patient outcomes. Two cell types stood out in high-score tumors: a set of support cells tied to inflammation and a group of immune cells marked by a fat-handling protein. Signals passing between them through a protein pair called C3 and C3AR1 may push the immune cells toward a state that helps tumors grow. The authors name that pathway as a candidate target for future treatment.

Catalog record

CREATORJianhua Mu, Yitian Wang, Han Liu, Xuanhong He, Zhuangzhuang Li, Minxun Lu, Fan Tang, Yi Luo, Yong Zhou, Li Min, Chongqi Tu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE49 KB
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13509456

Browse the full library · About the Tower of Babel